← Eichor
Condition: Autosomal Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Autosomal

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
Phase 2 · 43 location(s) · Vertex Pharmaceuticals Incorporated · NCT07161037Research of Therapeutic Targets in the Frame of Nephronophthisis and Renal Associated Ciliopathies
NA · 1 location(s) · Imagine Institute · NCT06648044Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic On
Phase 2 · 2 location(s) · Fudan University · NCT05281003Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA
Phase N/A · 2 location(s) · Danish Dementia Research Centre · NCT05740683LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT04628078Dominantly Inherited Alzheimer Network (DIAN)
Phase N/A · 26 location(s) · Washington University School of Medicine · NCT00869817AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Phase 2 · 1 location(s) · Mitchell Cairo · NCT04099966Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease
Phase N/A · 2 location(s) · Weill Medical College of Cornell University · NCT05085704Analysis of Patients With Autosomal Dominant Polycystic Kidney
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06759142Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
Phase 2 · 28 location(s) · Shionogi · NCT07123155Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414Resistance Training Added to Aerobic Interval Training to Improve Aerobic Capacity and Muscle Mass in Women With Coronar
NA · 1 location(s) · University Medical Centre Ljubljana · NCT07354399Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
Phase 3 · 49 location(s) · The University of Queensland · NCT04939935A Trial to Compare Treatment With Surlorian (ARM210, S48168) to Placebo in Effects on Muscle Strength and Safety in Adul
Phase 2 · 9 location(s) · RyCarma Therapeutics, Inc. · NCT07560020Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT04712812A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-0
Phase 2 · 38 location(s) · Merck Sharp & Dohme LLC · NCT06961006Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First
Phase 1/Phase 2 · 51 location(s) · Merck Sharp & Dohme LLC · NCT06469944Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis
NA · 1 location(s) · Abu Dhabi Health Services Company · NCT06535542Parkinson's Disease Biomarkers in Nerve Cells in the Gut
Phase N/A · 1 location(s) · Weill Medical College of Cornell University · NCT05347407A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK
Phase 1 · 2 location(s) · University College, London · NCT06372821Natural History in Children up to 16 Years With Mild to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes
Phase N/A · 1 location(s) · Sensorion · NCT05402813Validation of the RADIAL Algorithm for Diagnosis of Autosomal Recessive Cerebellar Ataxia
NA · 8 location(s) · University Hospital, Strasbourg, France · NCT04261127Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Phase N/A · 52 location(s) · Ensoma · NCT06605378A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by
Phase 2/Phase 3 · 37 location(s) · Washington University School of Medicine · NCT05552157KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · 46 location(s) · Merck Sharp & Dohme LLC · NCT04165070Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
Phase N/A · 12 location(s) · University of Wisconsin, Madison · NCT05677880Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease
Phase 1 · 15 location(s) · AstraZeneca · NCT07228364CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS
Phase 4 · 1 location(s) · West China Hospital · NCT07612774Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
NA · 1 location(s) · The Cleveland Clinic · NCT05868668A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With
Phase 3 · 23 location(s) · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT04782258
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.